Inventor · disambiguated record
Anthony O. Caggiano
Also filed as: CAGGIANO ANTHONY · CAGGIANO ANTHONY F · CAGGIANO ANTHONY O
37 granted patents·24 pending applications·77 citations·filing 2001–2023
97Inventor score
Files withACORDA THERAPEUTICS INC45CAGGIANO ANTHONY O5COGNITION THERAPEUTICS INC3GRUSKIN ELLIOTT A3CAGGIANO ANTHONY1
Top patents by PatentIndex Score
61 records- 0192US9198951B2Therapeutic dosing of a neuregulin or a subsequence thereof for treatment or prophylaxis of heart failureACORDA THERAPEUTICS INC·Filed 2013·Granted Dec 1, 2015·10 cites·5 claims
- 0286US11141467B2Methods of reducing extravasation of inflammatory cellsACORDA THERAPEUTICS INC·Filed 2017·Granted Oct 12, 2021·2 cites·4 claims
- 0386US9956266B2Therapeutic dosing of a neuregulin or a subsequence thereof for treatment or prophylaxis of heart failureACORDA THERAPEUTICS INC·Filed 2015·Granted May 1, 2018·2 cites·12 claims
- 0485US8984808B2Vertical planter tray systemDANIELS MELISSA·Filed 2012·Granted Mar 24, 2015·20 cites·23 claims
- 0584US8679481B2Methods of reducing extravasation of inflammatory cellsGRUSKIN ELLIOTT A·Filed 2011·Granted Mar 25, 2014·3 cites·5 claims
- 0683US7485295B2Compositions and methods of using chondroitinase ABCI mutantsACORDA THERAPEUTICS INC·Filed 2006·Granted Feb 3, 2009·4 cites·13 claims
- 0781US9410141B2Compositions and methods of using chondroitinase ABCI mutantsACORDA THERAPEUTICS INC·Filed 2015·Granted Aug 9, 2016·2 cites·16 claims
- 0881US7722864B2Compositions and methods of using chondroitinase ABCI mutantsACORDA THERAPEUTICS INC·Filed 2007·Granted May 25, 2010·3 cites·32 claims
- 0980US9757429B2Methods for detecting cardiac damageACORDA THERAPEUTICS INC·Filed 2016·Granted Sep 12, 2017·2 cites·11 claims
- 1079US7731956B2Compositions and methods of using chondroitinase ABCI mutantsACORDA THERAPEUTICS INC·Filed 2008·Granted Jun 8, 2010·2 cites·13 claims
- 1178US9102930B2Compositions and methods of using chondroitinase ABCI mutantsACORDA THERAPEUTICS INC·Filed 2013·Granted Aug 11, 2015·2 cites·21 claims
- 1278US7968089B2Proteoglycan degrading mutants for the treatment of CNSACORDA THERAPEUTICS INC·Filed 2008·Granted Jun 28, 2011·2 cites·34 claims
- 1377US9329171B2Methods for detecting cardiac damageACORDA THERAPEUTICS INC·Filed 2014·Granted May 3, 2016·2 cites·11 claims
- 1477US8852583B2Compositions and methods of using chondroitinase ABCI mutantsCAGGIANO ANTHONY O·Filed 2012·Granted Oct 7, 2014·2 cites·25 claims
- 1577US8410050B2Method for achieving desired glial growth factor 2 plasma levelsKIM HAESUN·Filed 2009·Granted Apr 2, 2013·4 cites·10 claims
- 1676US8404232B2Compositions and methods of using chondroitinase ABCI mutantsCAGGIANO ANTHONY O·Filed 2010·Granted Mar 26, 2013·2 cites·51 claims
- 1776US8236302B2Compositions and methods of using chondroitinase ABCI mutantsCAGGIANO ANTHONY O·Filed 2010·Granted Aug 7, 2012·2 cites·13 claims
- 1875US8628929B2Methods for detecting cardiac damageYAN XINHUA·Filed 2008·Granted Jan 14, 2014·3 cites·9 claims
- 1975US2011166068A1Therapeutic Dosing of a Neuregulin or a Subsequence Thereof for Treatment or Pro-phylaxis of Heart FailureACORDA THERAPEUTICS INC·Filed 2009·Application pending·0 cites
- 2073US9498515B2Compositions and methods for treatment during non-acute periods following CNS neurological injuryCAGGIANO ANTHONY·Filed 2009·Granted Nov 22, 2016·2 cites·16 claims
- 2173US9272015B2Method for achieving desired glial growth factor 2 plasma levelsACORDA THERAPEUTICS INC·Filed 2013·Granted Mar 1, 2016·1 cites·13 claims
- 2272US11071770B2Methods for detecting cardiac damageACORDA THERAPEUTICS INC·Filed 2019·Granted Jul 27, 2021·0 cites·7 claims
- 2371US7959914B2Methods of reducing extravasation of inflammatory cellsACORDA THERAPEUTICS INC·Filed 2004·Granted Jun 14, 2011·2 cites·8 claims
- 2469US11235031B2Therapeutic dosing of a neuregulin or a subsequence thereof for treatment or prophylaxis of heart failureACORDA THERAPEUTICS INC·Filed 2019·Granted Feb 1, 2022·0 cites·15 claims
- 2569US9839679B2Methods of reducing extravasation of inflammatory cellsACORDA THERAPEUTICS INC·Filed 2014·Granted Dec 12, 2017·0 cites·5 claims
- 2669US8226941B2Methods of purifying chondroitinase and stable formulations thereofCAGGIANO ANTHONY O·Filed 2005·Granted Jul 24, 2012·2 cites·17 claims
- 2768US10675331B2Method for achieving desired glial growth factor 2 plasma levelsACORDA THERAPEUTICS INC·Filed 2017·Granted Jun 9, 2020·0 cites·9 claims
- 2868US2023117985A1Use of neuregulin to treat peripheral nerve injuryACORDA THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 2968US2021060128A1Method for achieving desired glial growth factor 2 plasma levelsACORDA THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 3068US2018280477A1Therapeutic Dosing of a Neuregulin or a Subsequence Thereof for Treatment or Prophylaxis of Heart FailureACORDA THERAPEUTICS INC·Filed 2018·Application pending·0 cites
- 3166US10668131B2Compositions and methods for treatment during non-acute periods following CNS neurological injuryACORDA THERAPEUTICS INC·Filed 2016·Granted Jun 2, 2020·0 cites·7 claims
- 3264US9528102B2Proteoglycan degrading mutants for treatment of CNSACORDA THERAPEUTICS INC·Filed 2014·Granted Dec 27, 2016·0 cites·6 claims
- 3364US9402886B2Compositions and methods of using chondroitinase ABCI mutantsACORDA THERAPEUTICS INC·Filed 2014·Granted Aug 2, 2016·0 cites·8 claims
- 3464US8906363B2Fusion proteins for the treatment of CNSGRUSKIN ELLIOTT A·Filed 2004·Granted Dec 9, 2014·1 cites·8 claims
- 3564US2020368318A1Compositions and methods for treatment during non-acute periods following cns neurological injuryACORDA THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 3664US2018073007A9Fusion proteins for the treatment of cnsACORDA THERAPEUTICS INC·Filed 2014·Application pending·0 cites
- 3763US10323240B2Compositions and methods of using chondroitinase ABCI mutantsACORDA THERAPEUTICS INC·Filed 2017·Granted Jun 18, 2019·0 cites·11 claims
- 3862US10258667B2Methods for detecting cardiac damageACORDA THERAPEUTICS INC·Filed 2017·Granted Apr 16, 2019·0 cites·6 claims
- 3962US2020338165A1Therapeutic dosing of a neuregulin or a fragment thereof for treatment or prophylaxis of heart failureACORDA THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 4061US9987340B2Compositions and methods of using chondroitinase ABCI mutantsACORDA THERAPEUTICS INC·Filed 2016·Granted Jun 5, 2018·0 cites·12 claims
- 4161US2025177351A1Isoindoline compositions and methods for treating neurodegenerative diseaseCOGNITION THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 4260US9834764B2Compositions and methods of using chondroitinase ABCI mutantsACORDA THERAPEUTICS INC·Filed 2016·Granted Dec 5, 2017·0 cites·10 claims
- 4359US2017137799A1Proteoglycan degrading mutants for treatment of cnsACORDA THERAPEUTICS INC·Filed 2016·Application pending·0 cites
- 4458US9744215B2Method for achieving desired glial growth factor 2 plasma levelsACORDA THERAPEUTICS INC·Filed 2016·Granted Aug 29, 2017·0 cites·9 claims
- 4558US2020016247A1Compositions and methods for the treatment of cns injuriesACORDA THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 4657US7429375B2Proteoglycan degrading mutants for the treatment of CNSACORDA THERAPEUTICS INC·Filed 2004·Granted Sep 30, 2008·0 cites·12 claims
- 4757US2024165077A1Compositions and methods for treating neurologic diseasesCOGNITION THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 4856US2014248253A1Compositions and methods for the treatment of cns injuriesACORDA THERAPEUTICS INC·Filed 2014·Application pending·0 cites
- 4956US2024009168A1Compositions for treating dry age-related macular degeneration (amd)COGNITION THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 5055US2016129084A1Therapeutic Dosing of a Neuregulin or a Fragment Thereof for Treatment or Prophylaxis of Heart FailureACORDA THERAPEUTICS INC·Filed 2014·Application pending·0 cites
Showing the top 50 of 61 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Anthony O. Caggiano files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →